Janice M Rusnak

Summary

Affiliation: Walter Reed Army Medical Center
Country: USA

Publications

  1. ncbi Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
    Janice M Rusnak
    Special Immunizations Clinic, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702, USA
    J Occup Environ Med 46:801-11. 2004
  2. ncbi Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers
    Janice M Rusnak
    Special Immunizations Clinic, U S Army Medical Research Institute of Infectious Diseases USAMRIID, Fort Detrick, Maryland 21702, USA
    Biosecur Bioterror 2:281-93. 2004
  3. ncbi Management guidelines for laboratory exposures to agents of bioterrorism
    Janice M Rusnak
    Special Immunizations Clinic, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702, USA
    J Occup Environ Med 46:791-800. 2004
  4. ncbi Laboratory exposures to staphylococcal enterotoxin B
    Janice M Rusnak
    Special Immunizations Clinic, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702, USA
    Emerg Infect Dis 10:1544-9. 2004
  5. ncbi Botulinum neurotoxin vaccines: Past history and recent developments
    Janice M Rusnak
    Clinical Research Management, Inc, USA
    Hum Vaccin 5:794-805. 2009
  6. ncbi Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea
    Janice M Rusnak
    Division of Medicine, U S Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA
    Antiviral Res 81:68-76. 2009
  7. ncbi Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities
    Zygmunt F Dembek
    US Army Medical Research Institute of Infectious Diseases, 1425 Porter St, Ft Detrick, MD 21702, USA
    Disaster Med Public Health Prep 1:122-34. 2007
  8. ncbi Botulinum neurotoxin vaccines: past, present, and future
    Leonard A Smith
    Integrated Toxicology Division, US Army Medical Research Institute of Infectious Diseases Fort Detrick, MD 21702 5011, USA
    Crit Rev Immunol 27:303-18. 2007
  9. ncbi Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit
    Mark G Kortepeter
    US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA
    Emerg Infect Dis 14:881-7. 2008
  10. ncbi Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study
    Janice M Rusnak
    Clinical Research Management, Inc, Special Immunizations Program, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702, United States
    Vaccine 29:3222-9. 2011

Detail Information

Publications11

  1. ncbi Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
    Janice M Rusnak
    Special Immunizations Clinic, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702, USA
    J Occup Environ Med 46:801-11. 2004
    ..A multifaceted policy of personal protective measures, vaccination, early assessment, and postexposure antibiotic prophylaxis was effective in minimizing morbidity and mortality in at-risk laboratory workers...
  2. ncbi Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers
    Janice M Rusnak
    Special Immunizations Clinic, U S Army Medical Research Institute of Infectious Diseases USAMRIID, Fort Detrick, Maryland 21702, USA
    Biosecur Bioterror 2:281-93. 2004
    ..The data support the idea that research with these agents should be restricted to laboratories with experience in handling highly hazardous agents and where appropriate safety training and precautions can be implemented...
  3. ncbi Management guidelines for laboratory exposures to agents of bioterrorism
    Janice M Rusnak
    Special Immunizations Clinic, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702, USA
    J Occup Environ Med 46:791-800. 2004
    ..Algorithms for evaluating and managing potential exposures are presented to provide guidance to other agencies as they begin to work with these agents...
  4. ncbi Laboratory exposures to staphylococcal enterotoxin B
    Janice M Rusnak
    Special Immunizations Clinic, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702, USA
    Emerg Infect Dis 10:1544-9. 2004
    ..Symptoms from these patients and review of clinical symptoms of 16 laboratory-acquired inhalational SEB intoxications may help healthcare workers evaluate and identify SEB exposures in laboratory personnel at risk...
  5. ncbi Botulinum neurotoxin vaccines: Past history and recent developments
    Janice M Rusnak
    Clinical Research Management, Inc, USA
    Hum Vaccin 5:794-805. 2009
    ..Due to declining immunogenicity of the PBT, research efforts have been directed at development of both improved (less local reactogenicity) botulinum toxoids and recombinant vaccines as potential vaccine candidates to replace the PBT...
  6. ncbi Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea
    Janice M Rusnak
    Division of Medicine, U S Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA
    Antiviral Res 81:68-76. 2009
    ....
  7. ncbi Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities
    Zygmunt F Dembek
    US Army Medical Research Institute of Infectious Diseases, 1425 Porter St, Ft Detrick, MD 21702, USA
    Disaster Med Public Health Prep 1:122-34. 2007
    ..Due to declining immunogenicity and potency of the pentavalent botulinum toxoid, novel vaccine candidates are being developed...
  8. ncbi Botulinum neurotoxin vaccines: past, present, and future
    Leonard A Smith
    Integrated Toxicology Division, US Army Medical Research Institute of Infectious Diseases Fort Detrick, MD 21702 5011, USA
    Crit Rev Immunol 27:303-18. 2007
    ..Results from that study demonstrated that the recombinant bivalent vaccine was safe and well tolerated at all dosage levels tested and stimulated serotype-specific neutralizing antibodies among the majority of vaccine recipients...
  9. ncbi Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit
    Mark G Kortepeter
    US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA
    Emerg Infect Dis 14:881-7. 2008
    ..Research facilities contemplating work with pathogens requiring Biosafety Level 4 laboratory precautions should be mindful of the occupational health issues highlighted in this article...
  10. ncbi Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study
    Janice M Rusnak
    Clinical Research Management, Inc, Special Immunizations Program, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702, United States
    Vaccine 29:3222-9. 2011
    ..The data support the safety and immunogenicity of the inactivated RVF vaccine, and may serve as a standard of comparison for immunogenicity and safety for future RVF vaccines...
  11. ncbi History of U.S. military contributions to the study of parasitic diseases
    Nancy F Crum
    Infectious Disease Division, Naval Medical Center San Diego, San Diego, CA 92134, USA
    Mil Med 170:17-29. 2005
    ..We review the paramount U.S. military contributions to the understanding of leishmaniasis, filariasis, schistosomiasis, trypanosomiasis, gastrointestinal parasites, intestinal capillariasis, and angiostrongyliasis...